HTLV-1 Hbz protein, but not hbz mRNA secondary structure, is critical for viral persistence and disease development
PLOS Pathogens · 2023
DOI: 10.1371/journal.ppat.1011459 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Pathogens, 2023. Verfasst von Victoria Maksimova und 8 weiteren Autor:innen. Beteiligte Einrichtung: Center for Retrovirus Research, Department of Veterinary Biosciences, College of Veterinary Medicine, The Ohio State University, Columbus, Ohio, Unit…. Hauptthemen laut MEDLINE: Human T-lymphotropic virus 1, Leukemia-Lymphoma, Adult T-Cell. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIH NCI, The Ohio State University Pelotonia Fellowship Program.
Abstract (Originalsprache)
Human T-cell leukemia virus type 1 (HTLV-1) is the etiologic cause of adult T-cell leukemia/lymphoma (ATL) and encodes a viral oncoprotein (Hbz) that is consistently expressed in asymptomatic carriers and ATL patients, suggesting its importance in the development and maintenance of HTLV-1 leukemic cells. Our previous work found Hbz protein is dispensable for virus-mediated T-cell immortalization but enhances viral persistence. We and others have also shown that hbz mRNA promotes T-cell proliferation. In our current studies, we evaluated the role of hbz mRNA on HTLV-1-mediated immortalization in vitro as well as in vivo persistence and disease development. We generated mutant proviral clones to examine the individual contributions of hbz mRNA, hbz mRNA secondary structure (stem-loop), and Hbz protein. Wild-type (WT) and all mutant viruses produced virions and immortalized T-cells in vitro . Viral persistence and disease development were also evaluated in vivo by infection of a rabbit model and humanized immune system (HIS) mice, respectively. Proviral load and sense and antisense viral gene expression were significantly lower in rabbits infected with mutant viruses lacking Hbz protein compared to WT or virus with an altered hbz mRNA stem-loop (M3 mutant). HIS mice infected with Hbz protein-deficient viruses showed significantly increased survival times compared to animals infected with WT or M3 mutant virus. Altered hbz mRNA secondary structure, or loss of hbz mRNA or protein, has no significant effect on T-cell immortalization induced by HTLV-1 in vitro ; however, the Hbz protein plays a critical role in establishing viral persistence and leukemogenesis in vivo .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Center for Retrovirus Research, Department of Veterinary Biosciences, College of Veterinary Medicine, The Ohio State University, Columbus, Ohio, United States.
- Department of Biomedical Informatics, College of Medicine, The Ohio State University, Columbus, Ohio, United States.
- Comprehensive Cancer Center and Solove Research Institute, The Ohio State University, Columbus, Ohio, United States.
ORCID-Profile: Amanda R Panfil
Förderung
- NCI NIH HHS
- NIH NCI
- The Ohio State University Pelotonia Fellowship Program
Zitieren
APA
Maksimova, V., Wilkie, T., Smith, S., Phelps, C., Melvin, C., Yu, L., Niewiesk, S., Green, P. L., & Panfil, A. R. (2023). HTLV-1 Hbz protein, but not hbz mRNA secondary structure, is critical for viral persistence and disease development. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1011459
Vancouver
Maksimova V, Wilkie T, Smith S, Phelps C, Melvin C, Yu L, et al. HTLV-1 Hbz protein, but not hbz mRNA secondary structure, is critical for viral persistence and disease development. PLOS Pathogens. 2023. doi:10.1371/journal.ppat.1011459
BibTeX
@article{Maksimova2023,
author = {Maksimova, Victoria and Wilkie, Tasha and Smith, Susan and Phelps, Cameron and Melvin, Corrine and Yu, Lianbo and Niewiesk, Stefan and Green, Patrick L and Panfil, Amanda R},
title = {HTLV-1 Hbz protein, but not hbz mRNA secondary structure, is critical for viral persistence and disease development},
journal = {PLOS Pathogens},
year = {2023},
doi = {10.1371/journal.ppat.1011459}
}
EUVIMED